Status:
COMPLETED
Chart Review of Antivirals for Influenza in Infants
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Influenza
Eligibility:
All Genders
Up to 11 years
Brief Summary
This retrospective study conducted in Canada and the US involves a chart review to assess the safety of oseltamivir (Tamiflu®) compared to alternate antiviral therapy, amantidine or rimantidine, admin...
Detailed Description
The study is a retrospective review of charts of children less than 12 months of age that were diagnosed with influenza and treated with oseltamivir. The chart review will focus on assessment of neuro...
Eligibility Criteria
Inclusion
- Male or female study participants less than 12 months of age
- Suspected or laboratory diagnosis of influenza
- Treated with oseltamivir, rimantadine or amantadine
Exclusion
- None listed
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00311701
Start Date
November 1 2005
End Date
December 1 2006
Last Update
May 13 2011
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233-0011
2
Arkansas Children's Hospital
Pulaski, Arkansas, United States, 72202
3
Children's Hospital of Orange County
Orange, California, United States, 92868
4
Children's Hospital and Health Center
San Diego, California, United States, 92123